Patent 11332485 was granted and assigned to Venatorx Pharmaceuticals Inc. on May, 2022 by the United States Patent and Trademark Office.
Described herein are certain boron-containing compounds, compositions, preparations and their use as modulators of the transpeptidase function of bacterial penicillin-binding proteins and as antibacterial agents. In some embodiments, the compounds described herein inhibit penicillin-binding proteins. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.